Cris Bergerot, PhD
Advancing oncology care through research, innovation, and multidisciplinary collaboration. Passionate about patient-centered solutions, PROs, HRQOL, and evidence-based practices, w a focus on #GUOnc, #GeriOnc & #PallOnc
#ASCO25 FCOI: bit.ly/344gKxq
- Reposted by Cris Bergerot, PhDAnytime we can join @chadinabhan.bsky.social for a special #HealthcareUnfiltered episode, we're all in. I was pleased to join @shaalanbeg.bsky.social & @shrutipatelmd.bsky.social to highlight data from @ascocancer.bsky.social #GI26 Listen or watch the #podcast: podcasts.apple.com/us/podcast/e...
- Reposted by Cris Bergerot, PhDIPOS Webinar Recording Now Available. As part of World Cancer Day 2026, IPOS hosted a webinar on February 4 to spotlight the key findings from the Lancet Oncology Commission report, “The Human Crisis in Cancer.” For information and to purchase the recording ipos-society.org/event-6556328
- Reposted by Cris Bergerot, PhDIt’s the story of a group of experts, who are bringing insights on the latest science... Announcing our lineup of experts who'll serve as #GU26 Featured Voices, sharing which abstracts they’re most interested in, putting the findings into context & taking you along for the journey.
- Reposted by Cris Bergerot, PhD2026 IS HERE – IPOS is accepting new members and renewals for 2026! Being a member of IPOS means the opportunity to engage with professionals from 124 countries. If you have already joined/renewed for 2026, THANK YOU! If you have not, NOW IS THE TIME! ipos-society.org/membership/a...
- Reposted by Cris Bergerot, PhDThe 2026 NCCN Guidelines for Patients are now available. These guidelines provide trusted, patient-friendly information to help people understand kidney cancer diagnosis and treatment options. You can now find the updated guidelines at www.patients.kidneycan.org #AcceleratingCures
- Reposted by Cris Bergerot, PhDThe path to optimal cancer care is a shared one. As we recognize #WorldCancerDay, ASCO CMO Dr. @jrgralow.bsky.social reflects on the importance of trust, engagement, and empowerment in the patient journey. Read in @@usatoday.com: bit.ly/3ZVeV2J #UnitedByUnique
- Reposted by Cris Bergerot, PhDHappening soon: The "Best of SWOG" online research showcase. Catch up on some of the most notable @swog.org research results from the past year. Hope to see you there! #SWOGonc Register for this one-hour event: tinyurl.com/598z654w
- Reposted by Cris Bergerot, PhDJoin IPOS for World Cancer Day 2026: A Special Webinar on “The Human Crisis in Cancer” on February 4 from 8 to 9:30 a.m. ET. This is a live webcast and is open to all for FREE! Almost 300 registrations received. Have you registered yet? www.ipos-society.org/event-6480465
- Reposted by Cris Bergerot, PhDWe’re excited to share our newly updated Patient Resource Center! Created with input from patients, caregivers, & medical experts, it brings together clear, trusted information to help you navigate #KidneyCancer with confidence. Explore what’s new at www.patients.kidneycan.org #AcceleratingCures
- Reposted by Cris Bergerot, PhDThe power of #PalliativeCare! Timing of Specialist Palliative Care Consultation at a Comprehensive Cancer Center: A 7-Year Longitudinal Study @pallonccop.bsky.social @realbowtiedoc.bsky.social @mazietsangmd.bsky.social @crisbergerot.bsky.social ascopubs.org/doi/abs/10.1...
- Reposted by Cris Bergerot, PhDWhen the System Is the Treatment: Rethinking Nonpharmacologic Breakthroughs in Oncology Congratulations @rsedhom.bsky.social & colleagues! @pallonccop.bsky.social ascopubs.org/doi/full/10....
- Reposted by Cris Bergerot, PhDHappy New Year to all our followers. Mark your calendars for our first meeting of 2026, next Tuesday, with @linda-e-carlson.bsky.social and Sarah Bokovitz. DM for link and to be added to our mailing list. @realbowtiedoc.bsky.social @darcyburbage.bsky.social @ascocancer.bsky.social #pallsky
- Reposted by Cris Bergerot, PhDOnly three days left to vote in the ASCO Election! The voting period closes Monday, December 8, 2025, at 3:00 PM (ET), and all ballots must be received by that time. Eligible members are encouraged to learn more about each candidate and then make your voice heard at: www.asco.org/about-asco/a... 🗳️
- Reposted by Cris Bergerot, PhDJoin us #tomorrow 4p EST to hear Dr Tamryn Gray speak about #family centered caregiving as well as an update in #policy through the implementation of the #CARE act. DM for a link. #pallonc @crisbergerot.bsky.social @realbowtiedoc.bsky.social @tingtingzhang.bsky.social @fionnualacrowley.bsky.social
- Reposted by Cris Bergerot, PhDDay one of #COSAIPOS2025 is almost done! What a great day. Are you here? Make sure you come visit the IPOS and COSA lounge!
- Reposted by Cris Bergerot, PhDA letter to the editor discusses use of Olanzapine in cancer-associated cachexia, reporting possible short-term improvements in weight/appetite but raising uncertainty about long-term efficacy, risks and optimal patient selection. pubmed.ncbi.nlm.nih.gov/41213247/
- Reposted by Cris Bergerot, PhDVoting in the ASCO Election is open now until December 8! Meet the candidate for President-Elect, Deborah Schrag, MD, MPH, FASCO. Learn more about Dr. Schrag and make your voice heard at: brnw.ch/21wXn9K
- Reposted by Cris Bergerot, PhDTo be in the company of @mikkaelsekeres.bsky.social @crisbergerot.bsky.social is wild! Congrats to my fellow Fellows. I am so honored to be in your company and to be recognized by @ASCO
- Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wX0Hi
- Reposted by Cris Bergerot, PhDJoin us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wX0Hi
- Reposted by Cris Bergerot, PhD💚 As we close out #ASCOQLTY25, we are grateful to all of our attendees, in person and online, for being a part of the conversation as we work together to make progress in the quality, safety, and efficiency of #CancerCare delivery.
- Reposted by Cris Bergerot, PhDJoin us this Thursday to hear the highlights from #ASCOQLTY25 with #ASCOQLTY Chair Elect @ryannipp.bsky.social DM for the link or to be added to our mailing list. @realbowtiedoc.bsky.social @crisbergerot.bsky.social @ericroeland.bsky.social @fionnualacrowley.bsky.social #pallonc
- Reposted by Cris Bergerot, PhDFor #NSCLC patients, socio-demographics better predict distress levels than metastatic status—challenging common assumptions in psych-oncology. #ASCOQLTY25 #LungCancer #PsychosocialSupport www.CancerSupportCommunity.org Poster: www.cancersupportcommunity.org/sites/defaul...
- Reposted by Cris Bergerot, PhD💕 A big “thank you” to our #ASCOQLTY25 Featured Voices! Their expertise and insights are invaluable. We're so lucky to have them! @fumikochino.bsky.social @crisbergerot.bsky.social @ryannipp.bsky.social
- Reposted by Cris Bergerot, PhDHappening now at #ASCOQLTY25: Rapid Oral Abstract Session A ▶️ meetings.asco.org/2025-asco-qu... @crisbergerot.bsky.social @ryanhuey.bsky.social @christopherrios.bsky.social
- Reposted by Cris Bergerot, PhDGreat energy & dialogue in NYC this week during UN General Assembly & today’s High-level meeting on Non-Communicable Diseases & Mental Health. Working in collaboration we can (and must) accelerate efforts to improve outcomes in cancer & all NCDs globally. #UNGA2025 @ascocancer.bsky.social
- Reposted by Cris Bergerot, PhDMark your calendars for the year. DM to be added to our mailing list and never miss a meeting: @crisbergerot.bsky.social @realbowtiedoc.bsky.social @tingtingzhang.bsky.social @ericroeland.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social @darcyburbage.bsky.social @rsedhom.bsky.social
- Reposted by Cris Bergerot, PhDJoin us this evening 4pm EST! @crisbergerot.bsky.social @realbowtiedoc.bsky.social @tingtingzhang.bsky.social @fionnualacrowley.bsky.social @ericroeland.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social @darcyburbage.bsky.social @rsedhom.bsky.social
- This Thursday!! Join us for our kick-off meeting with our leaders @crisbergerot.bsky.social and @realbowtiedoc.bsky.social. DM for link @tingtingzhang.bsky.social @fionnualacrowley.bsky.social @ericroeland.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social @darcyburbage.bsky.social
- Reposted by Cris Bergerot, PhDThis Thursday!! Join us for our kick-off meeting with our leaders @crisbergerot.bsky.social and @realbowtiedoc.bsky.social. DM for link @tingtingzhang.bsky.social @fionnualacrowley.bsky.social @ericroeland.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social @darcyburbage.bsky.social
- Reposted by Cris Bergerot, PhDThe legendary @brueraeduardo.bsky.social discussing #survonc with long term #chronic toxicity and multi-dimensional #suffering. Love the #pallonc integration. #SuppOnc treats all patients and their suffering.
- Our next MASCC Short Talk features @brueraeduardo.bsky.social discussing how we can best partner with patients in managing chronic toxicities of cancer and its treatment Watch now: vimeo.com/1119840739 #MASCC25 #SuppOnc
- Reposted by Cris Bergerot, PhDYes it's that time of year again! #PallOncCoP is launching its Webinar Kick Off event in 2 weeks Sept 25th 4-5p EST. DM for a link or send your email to pallonccop@gmail.com to be added to the listserv. See you soon! #pallonc #supponc @crisbergerot.bsky.social @realbowtiedoc.bsky.social
- Reposted by Cris Bergerot, PhDMy favorite community connection every month! So glad we are restarting. Join my co-champ 🏆 @crisbergerot.bsky.social and I as we set the stage for @pallonccop.bsky.social 25-26. An amazing lineup of speakers. Join us Sept 25th
- Yes it's that time of year again! #PallOncCoP is launching its Webinar Kick Off event in 2 weeks Sept 25th 4-5p EST. DM for a link or send your email to pallonccop@gmail.com to be added to the listserv. See you soon! #pallonc #supponc @crisbergerot.bsky.social @realbowtiedoc.bsky.social
- Reposted by Cris Bergerot, PhD#GI26 is the perfect conference to showcase the best of #GIonc Don't miss out submit today! @crisbergerot.bsky.social @realbowtiedoc.bsky.social @tingtingzhang.bsky.social @ericroeland.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social @oncbrothers.bsky.social
- Hey, don’t forget to submit that #GI26 abstract! It’s your time to shine and help shape the future of GI cancer care with your #gicsm study in progress or a late-stage clinical trial. Abstracts are due Sept. 9 at 11:59 p.m. (ET). Learn more: brnw.ch/21wVvcH
- Reposted by Cris Bergerot, PhDInvesting in research today prevents suffering tomorrow & ensures our national scientific standing. We cannot turn away from millions counting on American ingenuity to live healthier lives. #ASCOAdvocacy #SaveResearchStopCancer Take action with us: brnw.ch/21wVvP3
- Reposted by Cris Bergerot, PhDFantastic to have this critical advice for older people with cancer - thank you @crisbergerot.bsky.social @bogda-koczwara.bsky.social and team
- 🚨New @ascocancer.bsky.social Guideline Alert! 🌍 Honored to have worked alongside #EnriqueSoto & cols in developing this guideline Check out the latest recommendations on GA, designed to improve care worldwide 📄Full guideline ascopubs.org/doi/pdf/10.1... 🎙️Don’t miss the accompanying podcast!
- Truly honored to be a featured voice at #ASCOQLTY25 alongside such inspiring colleagues who are shaping the future of quality cancer care Join us in Chicago & online, Oct 10–11, for sessions on shared decision-making, advancing quality cancer care and much more @ascocancer.bsky.social
- We’re excited to announce the ASCO Quality Care Symposium Featured Voices! Follow them before, during & after the event for expert insights & to be a part of the meeting experience. Join the conversation w/ the official hashtag #ASCOQLTY25. Registration is still open: brnw.ch/21wVoQS
- Reposted by Cris Bergerot, PhDShowcase your expertise to leaders in the international GU scientific community & generate fresh collaborations by sharing your research at #GU26—The Place to Be Heard. Submit an abstract to our 2026 ASCO Genitourinary Symposium by the Oct 21 deadline: brnw.ch/21wVrHY
- Reposted by Cris Bergerot, PhDWe’re excited to announce the ASCO Quality Care Symposium Featured Voices! Follow them before, during & after the event for expert insights & to be a part of the meeting experience. Join the conversation w/ the official hashtag #ASCOQLTY25. Registration is still open: brnw.ch/21wVoQS
- Reposted by Cris Bergerot, PhD⏰Discounted access to the 2025 @ascocancer.bsky.social Quality Care Symposium is ending soon! Join us at #ASCOQLTY25 the premier meeting addressing quality, safety, & efficiency of cancer care delivery. 📆 Early Registration by: Wed, September 3 at 11:59 PM (ET)
- Reposted by Cris Bergerot, PhD50 years ago, surviving cancer was a rarity. Federally funded research changed that for millions of Americans. But progress is now at risk. Unstable funding threatens to halt future breakthroughs #SaveResearchStopCancer #ASCOAdvocacy Take action with us: brnw.ch/21wVh17
- Reposted by Cris Bergerot, PhDThanks @crisbergerot.bsky.social for your constant support. An honor to champion @pallonccop.bsky.social alongside you! #pallonc #supponc
- Reposted by Cris Bergerot, PhDAn honor to collaborate with @rsedhom.bsky.social on this phenomenal podcast! #pallonc #supponc @tingtingzhang.bsky.social @fionnualacrowley.bsky.social @ericroeland.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social @darcyburbage.bsky.social
- Reposted by Cris Bergerot, PhDMachine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI
- 🚨New @ascocancer.bsky.social Guideline Alert! 🌍 Honored to have worked alongside #EnriqueSoto & cols in developing this guideline Check out the latest recommendations on GA, designed to improve care worldwide 📄Full guideline ascopubs.org/doi/pdf/10.1... 🎙️Don’t miss the accompanying podcast!
- 🎧 What if palliative care wasn’t just early, but precise? On the latest @ascocancer.bsky.social Daily News Podcast, Drs. #RamySedhom & @realbowtiedoc.bsky.social dive into precision palliative care - meeting patients’ real needs 👉 Listen now dailynews.ascopubs.org/do/podcast-p...
- Excited to share our new paper @eururoloncol.bsky.social !🎉We developed patient-centered, stage-specific FKSI-23 tools to better capture HRQOL in localized & metastatic RCC, moving beyond generic instruments to what truly matters to patients #TomPowles #MontyPal www.sciencedirect.com/science/arti...
- International perspectives on exercise oncology highlights progress, challenges, & opportunities to expand access to exercise in cancer care worldwide #JNCI @paulobergerot.bsky.social academic.oup.com/jncimono/art...
- Our study tested GAIN-S in older adults w metastatic cancer 🇧🇷 ➡️ GAIN-S improved emotional + adaptive aspects of prognostic awareness vs usual care Full paper acsjournals.onlinelibrary.wiley.com/doi/10.1002/... Thanks to #WilliamDale #EnriqueSoto @paulobergerot.bsky.social @ryannipp.bsky.social
- Congratulations to @realbowtiedoc.bsky.social and @mazietsangmd.bsky.social on this excellent editorial highlighting the future of performance status assessment in oncology 👏 Thank you for the kind shout-out; honored to see our work cited #JCOOP @ascocancer.bsky.social ascopubs.org/doi/10.1200/...
- Reposted by Cris Bergerot, PhDSafe and Responsible Use of Artificial Intelligence in Health Care: Current Regulatory Landscape and Considerations for Regulatory Policy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
- Reposted by Cris Bergerot, PhDA new global guideline on #geriatricassessment is here! Get the details and see how it can impact patient care. Read more: brnw.ch/21wVfLW
- Reposted by Cris Bergerot, PhDRESEARCH WEBINAR SERIES | Join us for a webinar by the Daffodil Centre's Triple I (Innovation-Implementation-Impact) stream: Implementation of equitable care across the cancer continuum 📆 Thursday 11 September 🕝 2:30 - 4:00PM AEST 📍 Online (Zoom) REGISTER TODAY uni-sydney.zoom.us/webinar/regi...
- Reposted by Cris Bergerot, PhDA summer 🌞 of firsts. Overjoyed to share my #inaugural editorial with 🥇 peer mentor @mazietsangmd.bsky.social in JCO-OP @ascocancer.bsky.social 🤖⏱️ #Wearable tech is transforming #SuppOnc and how we assess patient fitness 🏋️♀️ 🔗: ascopubs.org/doi/10.1200/...
- Reposted by Cris Bergerot, PhDGero-onc matters. “Effectiveness of comprehensive geriatric assessment with extensive patient coaching for improving quality of life in older patients with solid tumours receiving systemic therapy (G-oncoCOACH): a multicentre randomised controlled trial” - The Lancet @drjunejd.bsky.social
- Reposted by Cris Bergerot, PhDJoin us at #GI26 to learn about the latest diagnostic and therapeutic strategies in GI cancers to transform your patient outcomes in a program planned by and featuring multidisciplinary experts. Register today: brnw.ch/21wV49s
- Reposted by Cris Bergerot, PhD
- Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI
- Reposted by Cris Bergerot, PhDCan devices worn during chemotherapy capture prognostic information about physical function? We found that Fitbit metrics predicted overall survival, even after adjusting for clinician-rated performance status and patient-reported physical function: ascopubs.org/doi/10.1200/...
- Reposted by Cris Bergerot, PhD🎙 @realbowtiedoc.bsky.social & @rsedhom.bsky.social of @pennmedicine.bsky.social discuss a new strategy called precision palliative care – getting the right support to the right patient at the right time – on the latest episode of the #ASCODailyNews Podcast: brnw.ch/21wUB0b
